Cefixime USP 400mg Capsule.
Cefixime is generally classified as a third-generation cephalosporin antibiotic and is given by mouth in the treatment of susceptible infections, including gonorrhoea, otitis media, pharyngitis, lower respiratory-tract infections such as bronchitis and urinary tract infections and Shigellosis, caused by Shigella flexneri (54%), S. boydii (30%), S. dysenteriae non-type 1 (6%) and S. Sonnei (10%).
Cefixime USP 400mg Capsule.
Cefixime is generally classified as a third-generation cephalosporin antibiotic and is given by mouth in the treatment of susceptible infections, including gonorrhoea, otitis media, pharyngitis, lower respiratory-tract infections such as bronchitis and urinary tract infections and Shigellosis, caused by Shigella flexneri (54%), S. boydii (30%), S. dysenteriae non-type 1 (6%) and S. Sonnei (10%).
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.